Cargando…

Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review

During the course of treating non-small cell lung cancer (NSCLC) with epithelial growth factor receptor (EGFR) mutant, gefitinib resistance (GR) is unavoidable. As the environment for tumor cells to grow and survive, tumor microenvironment (TME) can significantly affect therapeutic response and clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mu-Tong, Li, Bai-Zhi, Zhang, En-Pu, Zheng, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553124/ https://www.ncbi.nlm.nih.gov/pubmed/37800802 http://dx.doi.org/10.1097/MD.0000000000035086

Ejemplares similares

Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer: A meta-analysis
por: Zhang, Wenxiong, et al.
Publicado: (2018)

Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer
por: Li, Fanghua, et al.
Publicado: (2023)

Erlotinib as a salvage treatment after gefitinib failure for advanced non-small-cell lung cancer patients with brain metastasis: A successful case report and review
por: Dong, Yong, et al.
Publicado: (2021)

Exploration of genes and tumor infiltrating lymphocytes in female lung adenocarcinoma microenvironment that predicted prognosis
por: Wang, Lijun, et al.
Publicado: (2021)

PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma
por: Li, Zhengtian, et al.
Publicado: (2021)

Lung adenocarcinoma organoids harboring EGFR 19Del and L643V double mutations respond to osimertinib and gefitinib: A case report
por: Bie, Yanan, et al.
Publicado: (2021)

Definitive local therapy for extracranial single-organ oligorecurrent non-small-cell lung cancer: A single institutional retrospective study
por: Jin, Jia-Nan, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis of the role of VWF in the tumor microenvironment of malignant mesothelioma
por: Weng, Jiren, et al.
Publicado: (2023)

Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma
por: Zhang, Xinyu, et al.
Publicado: (2022)

Establishment of a prognostic prediction system based on tumor microenvironment of pancreatic cancer
por: Feng, Yan, et al.
Publicado: (2022)

The role of CXCL10 in prognosis of patients with colon cancer and tumor microenvironment remodeling
por: Song, Weiwei, et al.
Publicado: (2021)

Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials
por: Li, Qing, et al.
Publicado: (2017)

Pan-cancer analyses reveal GTSE1 as a biomarker for the immunosuppressive tumor microenvironment
por: Tan, Ke, et al.
Publicado: (2023)

TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma
por: Lu, Qin, et al.
Publicado: (2023)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Activity of ceritinib in crizotinib-resistant ROS1-rearranged non-small-cell lung cancer patients
por: Zhang, Huixian, et al.
Publicado: (2023)

The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review
por: Xian, Feng, et al.
Publicado: (2023)

Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide: A case report and literature review
por: Yang, Yi, et al.
Publicado: (2020)

Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases
por: Huang, Zhangheng, et al.
Publicado: (2020)

Cuproptosis-associated genes and immune microenvironment characterization in breast cancer
por: Shen, Lijuan, et al.
Publicado: (2022)

Combined use of circulating tumor cells and salivary mRNA to detect non–small-cell lung cancer
por: Gu, Xianwen, et al.
Publicado: (2020)

Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer
por: Lee, Dong Soo, et al.
Publicado: (2015)

A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets
por: Qin, Yuan-Yuan, et al.
Publicado: (2023)

Plasma lncRNA FEZF1-AS1 as a potential biomarker for diagnosis of non-small-cell lung carcinoma
por: Huang, Yajie, et al.
Publicado: (2020)

Identification of prognostic values of the transcription factor-CpG-gene triplets in lung adenocarcinoma: A narrative review
por: Lian, Duohuang, et al.
Publicado: (2022)

Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer
por: Ye, Xiaolan, et al.
Publicado: (2020)

Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)

Mutation differences in circulating tumor DNAs from non-small cell lung cancer patients between Uygur and Han populations
por: Wang, Yuli, et al.
Publicado: (2021)

Mining of clinical and prognosis related genes in the tumor microenvironment of endometrial cancer: A field synopsis of observational study
por: Li, Wenxue, et al.
Publicado: (2023)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report
por: Jiang, Yiqian, et al.
Publicado: (2021)

Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors
por: Chen, Kegong, et al.
Publicado: (2021)

Platinum versus immunotherapy for early resectable non-small cell lung cancer: A protocol for systematic review and meta analysis
por: Tong, Zhangwei, et al.
Publicado: (2020)

Lysosome-related genes: A new prognostic marker for lung adenocarcinoma
por: Hu, Zeyang, et al.
Publicado: (2023)

High dose of nimustine as an add-on treatment for small cell lung cancer with intracranial metastasis: A case report and literature review
por: Luo, Wei, et al.
Publicado: (2017)

The texture of collagen in the microenvironments of Merkel cell carcinoma
por: Laurito, Tiago Luders, et al.
Publicado: (2021)

Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015
por: Xu, Long, et al.
Publicado: (2019)

Metastatic Tumors of the Penis: A Report of 8 Cases and Review of the Literature
por: Zhang, Ke, et al.
Publicado: (2015)

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma
por: Ju, Qing, et al.
Publicado: (2021)

A nationwide analysis of desmoplastic small round cell tumor
por: Xiang, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ev7fjfsue8sc9nacn42iej6dqa